A carregar...
Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
Abstract AIM: To analyze the use of serum cancer antigen 19‐9 (CA19‐9), cancer antigen 125 (CA‐125) and carcinoembryogenic antigen (CEA) in predicting the malignant potential of mucinous ovarian tumor, and to assess the clinical factors associated with these tumors. METHODS: This retrospective study...
Na minha lista:
| Publicado no: | J Obstet Gynaecol Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons Australia, Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693209/ https://ncbi.nlm.nih.gov/pubmed/32830422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jog.14427 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|